cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Intellia Therapeutics Inc
115 own
40 watching
Current Price
$38.98
$-0.24
(-0.61%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
3,433.97M
52-Week High
52-Week High
76.45
52-Week Low
52-Week Low
32.435
Average Volume
Average Volume
0.77M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization3,433.97M
icon52-Week High76.45
icon52-Week Low32.435
iconAverage Volume0.77M
iconDividend Yield--
iconP/E Ratio--
What does the Intellia Therapeutics Inc do?
Intellia Therapeutics Inc., a gene editing company, focuses on the development of therapeutics utilizing a biological tool known as the CRISPR/Cas9 system. The company develops in vivo programs focused on liver diseases, including transthyretin amyloidosis, alpha-1 antitrypsin deficiency, hepatitis B virus, and inborn errors of metabolism; and ex vivo applications of the technology in chimeric antigen receptor T cell and hematopoietic stem cell product candidates. It has a strategic collaboration and license agreement with Novartis focused on the development of new ex vivo CRISPR/Cas9-based therapies. Intellia Therapeutics Inc. was formerly known as AZRN, Inc. and changed its name to Intellia Therapeutics Inc. in July 2014. The company was founded in 2014 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Intellia Therapeutics Inc make?
News & Events about Intellia Therapeutics Inc.
Benzinga
25days ago
Intellia Therapeutics, Inc.(NASDAQ: NTLA) shares are up Thursday as its Q1 results surpassed estimates. The company looks forward to sharing new interim data from NTLA-2001 and NTLA-2002 first-in-human studies in the coming months. read more...
Fool.com Headlines
1month ago
These stocks have some promising growth opportunities, but they also come with a fair amount of risk.Are you looking for some growth stocks than can double in value? Two stocks that analysts appear to be bullish on right now are Intellia Therapeutics (NASDAQ: NTLA) and Rivian Automotive(NASDAQ: RIVN...
Ticker Report
1month ago
Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA Get Rating) have received a consensus recommendation of Moderate Buy from the nineteen research firms that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell ...
Globe Newswire
2 months ago
NTLA-2002 is a single dose, in vivo genome editing candidate designed to prevent potentially life-threatening swelling attacks in people with HAECAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on ...
Ticker Report
3 months ago
Intellia Therapeutics (NASDAQ:NTLA Get Rating) had its price objective trimmed by Chardan Capital from $129.00 to $111.00 in a research report sent to investors on Friday, The Fly reports. NTLA has been the topic of several other research reports. Oppenheimer decreased their target price on ...
Frequently Asked Questions
Frequently Asked Questions
What is Intellia Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Intellia Therapeutics Inc shares?
plus_minus_icon
How can I buy Intellia Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Intellia Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Intellia Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Intellia Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Intellia Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Intellia Therapeutics Inc?
plus_minus_icon
What percentage is Intellia Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Intellia Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$38.98
$-0.24
(-0.61%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00